Dr. Fataneh Majlessipour, MD

Fataneh (Fae) Majlessipour, MD, is the Director of Pediatric Hematology/Oncology in the Department of Pediatrics at Cedars-Sinai Medical Center (CSMC). She is board certified in Pediatrics and Pediatric Hematology and Oncology. She is also an Associate Clinical Professor of pediatrics at David Geffen School of Medicine at Univeristy of California Los Angeles (UCLA).

Dr. Majlessipour earned her medical degree from the Isfahan School of Medicine, University of Medical Sciences, Isfahan, Iran. After a short stay in France, Dr. Majlessipour moved to US where she completed a pediatric internship and residency at Children’s Hospital of Orange County in Orange, California and a fellowship in Hematology-Oncology at Children's Hospital of Los Angeles, University of Southern California.

After completing her fellowship, Dr. Majlessipour assumed the role of Attending Physician at Loma Linda University Children’s Hospital in Loma Linda, California for eight years. In 2008, Dr. Majlessipour was appointed as Associate Director and in 2011 as Director of Pediatric Hematology-Oncology Program at Cedars-Sinai Medical Center in West Los Angeles. Dr. Majlessipour is also the Principal Investigator of Children Oncology Group at CSMC.

As an author, Dr. Majlessipour has published several articles in peer-reviewed journals such as “Blood”, “Anticancer Research”, and “Journal of Gastrointestinal Surgery”. She has lectured extensively on topics such as late effects of childhood cancer, pediatric brain tumors and more.

Dr. Majlessipour is a member of several professional societies, including the American Society of Hematology, the American Society of Pediatric Hematology-Oncology and the American Society of Clinical Oncology.

Dr. Majlessipour has been involved with many community services related to children with cancer since 2001: she served on “Board of Directors” of “Candlelighters of Inland Empire” from 2004 to 2006 and currently is a member of “Medical Advisory Board” for “The Bone Marrow Foundation” since 2013.

Twitter Facebook Linkedin Plusone Pinterest Email